Sun Pharmaceuticals
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Sun Pharmaceuticals as PDF for free.
More details
- Words: 366
- Pages: 8
SUN PHARMACEUTICALS
Introduction • Sun Pharmaceutical is an international pharmaceutical company based in Mumbai, India. • It makes many generic and brand name drugs that are distributed in the United States, Europe, Asia and worldwide. It makes many generic and brand name drugs that are distributed in the United States, Europe, Asia and worldwide.
INTRODUCTION • Sun manufactures both pharmaceuticals and active pharmaceutical ingredients (API). • Its products are in several therapeutic areas, including psychiatry, neurology, cardiology, diabetology, gastroenterology, respiratory, and orthopedics.
HISTORY • Established in 1983, Sun Pharma was a start-up company with five products. • Since 1996, Sun has grown largely through a combination of internal growth, and acquisition of other pharmaceutical companies. • For example, it bought US-based Caraco Pharm Labs, and ICN Hungary
HISTORY • Mr. Shanghvi founded the company in 1982. Dilip S. Shanghvi, Chairman and Managing Director. • Established in 1983, Sun Pharma was a startup company with five products. Mr. Shanghvi founded the company in 1982. • Since 1996, Sun has grown largely through a combination of internal growth, and acquisition of other pharmaceutical companies. • For example, it bought US-based Caraco Pharm Labs, and ICN Hungary
Mergers and acquisitions • Started with the purchase of Knoll Pharma's bulk actives manufacturing business based in Ahmednagar in 1996. • Sun also took a step to break into the important U.S. healthcare market, with its purchase of stake in Detroit-based Caraco Pharmaceutical Laboratories, which specialized in the manufacture of generic dosage form medications and gave Sun its first production plant approved by the U.S. Food and Drug Administration (USFDA).
Mergers and acquisitions • Also in 1996, Sun purchased a shareholding in Gujarat Lyka Organics, which brought Sun a USFDA-approved manufacturing facility. • The acquisition drive continued and in the same year it purchased a stake in MJ Pharmaceuticals Ltd., based in Halol. • 2002- Madras-based Pradeep Drug Company Ltd. • 2004- acquired a Cephalosporin Actives manufacturer, Phlox Pharma, with European approval
Mergers and acquisitions • In May 2007, Sun along with our subsidiaries, signed definitive agreements to acquire Taro. Pharmaceutical Industries Ltd., a multinational generic manufacturer with established subsidiaries, manufacturing and products across the U.S., Israel, and Canada for $454 million
Introduction • Sun Pharmaceutical is an international pharmaceutical company based in Mumbai, India. • It makes many generic and brand name drugs that are distributed in the United States, Europe, Asia and worldwide. It makes many generic and brand name drugs that are distributed in the United States, Europe, Asia and worldwide.
INTRODUCTION • Sun manufactures both pharmaceuticals and active pharmaceutical ingredients (API). • Its products are in several therapeutic areas, including psychiatry, neurology, cardiology, diabetology, gastroenterology, respiratory, and orthopedics.
HISTORY • Established in 1983, Sun Pharma was a start-up company with five products. • Since 1996, Sun has grown largely through a combination of internal growth, and acquisition of other pharmaceutical companies. • For example, it bought US-based Caraco Pharm Labs, and ICN Hungary
HISTORY • Mr. Shanghvi founded the company in 1982. Dilip S. Shanghvi, Chairman and Managing Director. • Established in 1983, Sun Pharma was a startup company with five products. Mr. Shanghvi founded the company in 1982. • Since 1996, Sun has grown largely through a combination of internal growth, and acquisition of other pharmaceutical companies. • For example, it bought US-based Caraco Pharm Labs, and ICN Hungary
Mergers and acquisitions • Started with the purchase of Knoll Pharma's bulk actives manufacturing business based in Ahmednagar in 1996. • Sun also took a step to break into the important U.S. healthcare market, with its purchase of stake in Detroit-based Caraco Pharmaceutical Laboratories, which specialized in the manufacture of generic dosage form medications and gave Sun its first production plant approved by the U.S. Food and Drug Administration (USFDA).
Mergers and acquisitions • Also in 1996, Sun purchased a shareholding in Gujarat Lyka Organics, which brought Sun a USFDA-approved manufacturing facility. • The acquisition drive continued and in the same year it purchased a stake in MJ Pharmaceuticals Ltd., based in Halol. • 2002- Madras-based Pradeep Drug Company Ltd. • 2004- acquired a Cephalosporin Actives manufacturer, Phlox Pharma, with European approval
Mergers and acquisitions • In May 2007, Sun along with our subsidiaries, signed definitive agreements to acquire Taro. Pharmaceutical Industries Ltd., a multinational generic manufacturer with established subsidiaries, manufacturing and products across the U.S., Israel, and Canada for $454 million
Related Documents
Sun Pharmaceuticals
June 2020 2
Pharmaceuticals - Be
November 2019 11
Torrent Pharmaceuticals
June 2020 5
Roche Pharmaceuticals
June 2020 7
Sun
November 2019 30